Page last updated: 2024-08-23

daunorubicin and Aggressive Systemic Mastocytosis

daunorubicin has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, H; Jiang, X; Wang, X; Zhang, L; Zhou, D	1

Other Studies

1 other study(ies) available for daunorubicin and Aggressive Systemic Mastocytosis

Article	Year
A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study. Medicine, 2020, Dec-11, Volume: 99, Issue:50 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; CD2 Antigens; Cytarabine; Dasatinib; Daunorubicin; DNA-Binding Proteins; Drug Therapy, Combination; Histamine Antagonists; Humans; Interleukin-2 Receptor alpha Subunit; Leukotriene Antagonists; Lymph Nodes; Male; Mastocytosis, Systemic; Mutation; Platelet Transfusion; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Sarcoma, Myeloid; Skin; Transcription Factors; Treatment Outcome	2020

Article

Year

A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study.

Medicine, 2020, Dec-11, Volume: 99, Issue:50

Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; CD2 Antigens; Cytarabine; Dasatinib; Daunorubicin; DNA-Binding Proteins; Drug Therapy, Combination; Histamine Antagonists; Humans; Interleukin-2 Receptor alpha Subunit; Leukotriene Antagonists; Lymph Nodes; Male; Mastocytosis, Systemic; Mutation; Platelet Transfusion; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Sarcoma, Myeloid; Skin; Transcription Factors; Treatment Outcome

2020